A Novel Computer-Based Treatment for Childhood Anxiety Disorders

Not Applicable

• Conditions: Anxiety; Mental Health - Anxiety

• Registration Number: ACTRN12612000988853
• Lead Sponsor: Dr Allison Waters

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Participants will be children aged between 7 and approximately 12-13 years old and will be presenting with a principal anxiety disorder as determined by the Anxiety Disorders Interview Schedule (ADIS) - parent and child interview schedules

Exclusion Criteria

Children with another psychiatric disorder as their principal (i.e., most severe disorder) other than anxiety disorders, organic brain damage, developmental disorders.
Children with vision impairment that would prevent them from completing the treatment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnosis<br>Anxiety Disorders Interview Schedule (ADIS) Child and Parent versions[Baseline, post-treatment and at 6 and 12 months after treatment completed];Symptoms<br>Assessed using several questionnaires:<br>- Spence Children's Anxiety Scale (SCAS)<br>- Child Behaviour Checklist (CBCL)<br>- Short Mood & Feelings Questionnaire (SMFQ)<br>- State Trait Anxiety Inventory for Children (STAI-C)<br>- Depression Anxiety Stress Scales (DASS)<br>- Quality of Life Scale (QOL)<br>- EMBU-P (Parenting Style questionnaire)<br>- Parent Sense of Satisfaction and Competence (PSOC)<br>- State Trait Anxiety Inventory (Adult) Trait Scale[Baseline, post-treatment and at 6 and 12 months after treatment completed];Cognitive<br>- Children's Automatic Thoughts Scale <br>- Attention Control Scale (ACS)<br>- Visual Probe Task (Computer task)<br>- Interference Task (Computer task)<br>- Threat interpretation bias task[Baseline, post-treatment and at 6 and 12 months after treatment completed]

Secondary Outcome Measures

Name	Time	Method
il[Nil]